Introduction
Physical interaction of activated receptor protein tyrosine kinases (PTKs) with Src-homology 2 (SH2)-containing target proteins presumably initiates multiple intracellular signaling pathways that regulate cell growth and dierentiation (Koch et al., 1991; Ullrich and Schlessinger, 1990) . The SH2 domain, a conserved noncatalytic region of approximately 100 amino acids, was found in a large group of cytoplasmic enzymes, including Src-family PTKs, tyrosine phosphatases (Shp-1, Shp-2), Ras GTPase activating protein (RasGAP), the regulatory 85 kDa subunit (p85) of phosphatidylinositol 3'-kinase (PI3K), phospholipase C-g (PLC-g), and in several adaptor proteins, such as Grb2, Nck and Crk (Cohen et al., 1995; Feng et al., 1993; Neel, 1993; Pawson and Gish, 1992) . Shp-2 is a ubiquitously expressed tyrosine phosphatase that possesses two SH2 domains at the N-terminus.
Although its physiological function is not de®ned, this phosphatase appears to participate in proximal events downstream of receptor PTKs, since Shp-2 physically interacts with and is transiently phosphorylated on tyrosine by receptor PTKs upon ligandbinding (Feng and Pawson, 1994; Neel, 1993) . Overexpression of a catalytically-inactive mutant of Shp-2 or microinjection of a truncated protein containing only the SH2 domains blocked mitogenic stimulation of Ras, extracellular signal regulated kinase (Erk) and DNA synthesis (Milarski and Saltiel, 1994; Noguchi et al., 1994; Xiao et al., 1994) . These results, together with the genetic analysis of its Drosophila homologue, corkscrew (Perkins et al., 1992) , suggest that Shp-2 might be a positive player in cytoplasmic signaling cascades.
A targeted mutant allele of the murine Shp-2 gene was created by deletion of exon 3, which encodes for amino acids 46 ± 110 in the N-terminal SH2 (SH2-N) domain (Saxton et al., 1997) . Homozygous mutant mice are embryo-lethal with multiple defects in the node, notochord and posterior elongation (Saxton et al., 1997) . These results suggest that Shp-2 is required for mesodermal patterning and posterior development during gastrulation, consistent with the previous observation in Xenopus embryos (Tang et al., 1995) . Injection of catalytically-inactive mutant Shp-2 mRNA into Xenopus embryos blocked mesodermal induction and caused truncation of terminal structures. Using homozygous Shp-2 mutant embryonic stem (ES) cells, we have also demonstrated that the deletion mutation in the Shp-2 locus dramatically aected hematopoietic cell dierentiation (Qu et al., 1997) . Development of both erythroid and myeloid cell lineages was severely suppressed in embryoid bodies of Shp-2 mutant origin. Activation of Erk activity by stem cell factor (SCF) was abolished in Shp-2 mutant ES cells. This positive regulatory role of Shp-2 for blood cell production in mammals stands in contrast to Shp-1 that serves as a negative eector in the hematopoietic compartment (D'Ambrosio et al., 1995; Kozlowski et al., 1993; Shultz et al., 1993; Tsui et al., 1993) . Since the homozygous mutant embryos die at approximately the same time of gestation as a null mutant of Shp-2 (Arrandale et al., 1996) and the heterozygotes appear to be normal, the mutant Shp-2 protein without the intact SH2-N domain does not function in a dominant negative manner and seems to be biologically inert.
The biochemical interaction between Shp-2 and platelet-derived growth factor receptors (PDGFRs) has received intensive studies. Shp-2 is complexed with PDGFR-a and PDGFR-b upon ligand activation, accompanied by a transient phosphorylation on tyrosine (Feng et al., 1994; Kazlauskas et al., 1993; Lechleider et al., 1993a) . Shp-2 binds to activated PDGFR-b by speci®cally recognizing phosphorylated tyrosine 1009 in the C-terminal tail, while its association with PDGFR-a is mediated by tyrosine 720 in the kinase insert region (Bazenet et al., 1996; Feng et al., 1994; Kazlauskas et al., 1993; Lechleider et al., 1993b) . However, it remains to be elucidated how Shp-2 acts to regulate signal relay downstream of PDGFRs.
This paper reports a rather surprising ®nding that Shp-2, while a signal transducer for PDGFR-a and -b, also functions to control speci®cally the PDGFR-b mRNA stability. This ®nding raises an intriguing possibility that a receptor substrate signals to a cellular event involved in the control of the receptor expression, a positive feedback mechanism.
Results

Downregulation of PDGFR-b in Shp-2 mutant ®broblast cells
In order to determine the Shp-2 function in cell signaling, we have established ®broblast cell lines derived from wild-type, heterozygous and homozygous Shp-2 mutant embryos (Shi et al., 1998) . To decipher the dynamic interaction of the Shp-2 tyrosine phosphatase with receptor PTKs, we ®rst examined expression levels of a number of growth factor receptors in mutant cells. The protein amounts of PDGFR-a, PDGFR-b, epidermal growth factor receptor (EGFR), and insulin-like growth factor-1 receptor (IGF-IR) were assessed by immunoblot analysis, and the results are shown in Figure 1a . Surprisingly, the level of PDGFR-b was dramatically reduced and hardly detectable in homozygous mutant cells, as compared to wild-type and heterozygous mutant cells. On the other hand, no signi®cant changes were observed for protein levels of PDGFRa and EGFR (Figure 1a ) and the expression of IGF-IR was not altered either (data not shown). The same result was obtained with at least ®ve homozygous mutant cell lines, each of which was originally derived from a separate embryo. This observation points to a speci®c eect of the targeted Shp-2 mutation on the control of PDGFR-b expression. As shown in Figure  1 , heterozygous mutant cell lines have the wild-type phenotype without signi®cant changes in the expression level of PDGFR-b. Thus, it is unlikely that the suppression of PDGFR-b was due to acquisition of a new function by the mutant Shp-2 protein.
Experiments were also performed to directly examine the level of PDGFR-b in primary ®broblast cells isolated from wild-type and mutant embryos. Consistently, a much reduced level of PDGFR-b expression was observed in homozygous Shp-2 mutant cells, as compared with heterozygous mutant and wildtype cells (Figure 1b ). This result helps excluding the possibility that there was a biased selection of PDGFR-b de®cient cells during the process of establishing the cell lines.
Impaired stability of PDGFR-b mRNA
Lower amounts of the PDGFR-b protein in homozygous Shp-2 mutant cells could be due to a faster . Cell lysates were made from wild-type (+/+), heterozygous (+/7) and homozygous (7/7) mutant ®broblasts. Protein concentration in cell lysates was measured using a Bio-Rad protein assay kit. Equal amounts of cell lysates (40 mg of total proteins) were resolved on 8% SDS-polyacrylamide gel and subjected to immunoblot analysis using speci®c antibodies to PDGFR-a, . Primary ®broblast cells isolated from E10.5 embryos were analysed by immunoblotting with speci®c antibodies to PDGFR-b and Shp-2 as above. (c). Wild-type cells were incubated with conditioned medium of mutant cells for 24 h. Lysates of control (O) and conditioned medium treated cells (CM) were made and the PDGFR-b expression was analysed by immunoblot using its speci®c antibody degradation or a rapid turnover of the receptor. Alternatively, a down modulation of its mRNA level may lead to a defective biosynthesis of the receptor protein. To detect any factors secreted by mutant cells that might downregulate the PDGFR-b, we prepared a supernatant collected from mutant cell cultures and incubated wild-type cells with the conditioned medium. Figure 1c shows that the expression level of PDGFR-b in wild-type cells was not altered following incubation with the conditioned medium for 24 h, suggesting that repression of PDGFR-b was not contributed by a downregulatory eect of any autocrine factors derived from mutant cells, but rather due to a decreased biosynthesis of the receptor.
Northern blot analysis was conducted to determine the transcript levels of PDGF receptor genes in mutant cells. Total RNAs were extracted from wild-type and mutant cells and analysed by hybridization using speci®c cDNA probes for PDGFR-a and PDGFR-b. As shown in Figure 2 , the mRNA for PDGFR-b was detected at high levels in heterozygous Shp-2 mutant cells, as well as in wild-type cells (data not shown). However, this speci®c transcript was barely detectable in homozygous mutant cells. Meanwhile, no signi®cant changes were observed for PDGFR-a mRNA levels between wild-type and mutant cells ( Figure 2 ).
These results suggest that the decrease of the PDGFR-b protein amount results from a speci®c reduction of its mRNA level in mutant cells, either due to a de®cient promoter activity or an enhanced degradation of the transcript. To further explore the molecular mechanism, we performed nuclear run-on experiment. Nuclei were isolated from both wild-type and mutant cells, and the transcription rate of promoters for PDGFR-a and PDGFR-b genes was examined by including the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene as an internal control. As shown in Figure 3 , similar or slightly decreased transcription initiation from these two promoters were observed in mutant cells, as compared to that in wildtype cells, suggesting that the selective and dramatic decrease of PDGFR-b mRNA level is not due to a problem in transcription initiation.
We then measured PDGFR-b mRNA stability in wild-type and mutant cells. As Northern blotting barely detected PDGFR-b mRNA in mutant cells, a more sensitive method, quantitative reverse transcriptase (RT) ± PCR analysis, was employed. Cells were treated with actinomycin D (10 mg/ml) to terminate transcription. Total RNAs were extracted at dierent time points and subjected to RT ± PCR measurement. As expected, signi®cantly reduced levels of RT ± PCR products speci®c for PDGFR-b mRNA were detected in mutant cells, compared to that in wild-type cells (Figure 4a ). More importantly, the degradation of this speci®c transcript was apparently much accelerated in mutant cells. The half-life of PDGFR-b mRNA was longer than 6 h in wild-type cells, but it was decreased to approximately 1 h in mutant cells (Figure 4b) . Meanwhile, the level and stability of the transcript for hypoxanthine phosphoribosyltransferase (HPRT), a house-keeping gene, was also compared by RT ± PCR analysis. A similar and a much longer half-life of HPRT mRNA was detected in mutant as well as in wild-type cells. Thus, poor stability of mRNA might have a major contribution to the defective expression of PDGFR-b in Shp-2 mutant cells, and the Shp-2 mutation appears to have a speci®c eect on accelerated decay of its mRNA.
Defective signaling downstream of PDGFR-b
PDGF is a homo-or hetero-dimer of A and B chains, PDGF-AA, -BB, and -AB, that bind with dierent anities to PDGFR-a and -b. PDGF-BB activates aa, bb and ab receptor dimers, while PDGF-AA stimulates only the aa receptor homodimer. Following ligand activation, PDGFR-a and -b bind to some common downstream targets including PLC-g, PI3K, the Src kinase, and Shp-2. However, RasGAP binds only to PDGFR-b but not to PDGFR-a. Stimulation of cells expressing only PDGFR-a with PDGF-BB does not induce tyrosine phosphorylation of RasGAP (Bazenet and Kazlauskas, 1994; Heidaran et al., 1993) . Since the expression of PDGFR-b was defective in Shp-2 mutant cells, we examined the response of RasGAP to PDGF-BB stimulation. Cells were treated with PDGF-BB for 5 min and cell lysates were made. RasGAP was Figure 2 Northern blot analysis of PDGFR mRNAs. Total RNA (10 mg) was separated on 1% agarose gel containing formaldehyde, transferred to a nylon ®lter and hybridized to 32 P-labeled probes speci®c for PDGFR-a or PDGFR-b (kindly provided by Dr Philippe Soriano), according to standard protocols Figure 3 Nuclear run-on assay. Nuclei were isolated from wildtype (+/+) and mutant (7/7) cells according to a previously published protocol (Greenberg and Zi, 1984) . Nuclear run-on assay was performed as described in the text for determination of PDGFR-a and PDGFR-b gene transcription initiation. GAPDH cDNA and the pBluescript vector DNA were included as positive and negative controls, respectively immunoprecipitated with its speci®c antibody from control and factor-stimulated cell lysates, and subjected to immunoblot analysis using anti-phosphotyrosine (anti-PY) antibody. A signi®cant tyrosinephosphorylation of RasGAP was detected in heterozygous mutant cells (Figure 5a ) and wild-type cells (data not shown). In contrast, the induction of GAP phosphorylation on tyrosine was apparently blocked in homozygous mutant cells, although there is a slight increase of the basal level in unstimulated cells (Figure 5a ). Meanwhile, we examined induction of PLC-g phosphorylation under stimulation of PDGF-AA or -BB. As shown in Figure 5b and c, a modest increase in the background level of PLC-g phosphorylation on tyrosine was detected in mutant cells as compared to wild-type cells. The induction of PLC-g phosphorylation by PDGF-AA seemed to be enhanced in mutant cells, but the increase fold was actually not changed between wild-type and mutant cells, given the elevated basal level in the latter. On the other hand, PDGF-BB induction of PLC-g phosphorylation was slightly reduced in mutant cells ( Figure 5c ). As shown in Figure 5 , the protein amounts of RasGAP and PLC-g were not altered in mutant cells. Thus, the change in the phosphorylation pro®le of RasGAP and PLC-g in response to PDGF is correlated with the dierent expression pattern of PDGFR-a and PDGFR-b in Shp-2 mutant cells. Alteration in the basal levels of RasGAP and PLC-g might re¯ect a possible interaction between Shp-2 and these signaling molecules, all of which appear to operate in proximal events downstream of receptor PTKs.
Mitogenic response to PDGF
The ability of PDGF-AA and PDGF-BB to elicit a mitogenic response in wild-type and mutant cells was investigated by [ PDGF stimulation of cells normally induces a transient activation of Erk kinases, a group of mitogen-activated protein (MAP) kinases, in association with cell proliferation. Using myelin basic protein (MBP) as a substrate, we measured Erk activation by PDGF-BB in wild-type and mutant cells. Erk protein was immunoprecipitated using its speci®c antibody from control and factor-stimulated cell lysates and the kinase activity was assayed as previously described (Shi et al., 1998) . As shown in Figure 7 , the induction of Erk activity by PDGF-BB, although not completely blocked, was severely suppressed in homozygous Shp-2 mutant cells, as compared to that in wild-type cells. This result is at odds with the previously published data that Erk activation by PDGF-BB was a bit higher in Shp-2 mutant cells than in wild-type cells (Saxton et al., 1997) , which might be due to dierent methods of Erk kinase assay used in the two studies. Consistent with the thymidine incorporation data shown above, we have also observed an impaired stimulation of Erk activity by PDGF-AA in homozygous mutant cells (Shi et al., 1998) .
Discussion
We report here an unexpected observation that PDGFR-b mRNA is rapidly degraded in cells lacking a functional Shp-2 protein, which leads to a defective a b Figure 4 Stability of PDGFR-b mRNA. (a). RT ± PCR analysis was performed to examine the decay of PDGFR-b mRNA. Actinomycin D (10 mg/ml) was added to wild-type (+/+) or mutant (7/7) cells. Total RNA was isolated after 0, 1, 2, 4, 6 h of actinomycin D addition. Levels of PDGFR-b mRNA were determined by RT ± PCR in the presence of [a-32 P]dCTP. PCR products were resolved on SDS-polyacrylamide gel, dried and exposed to X-ray ®lm. (b). Half-life of PDGFR-b mRNA. The band density in a was measured by densitometric scanning, and relative PDGFR-b mRNA levels in each sample were calculated by comparing to the mRNA amount at 0 h. The half-life of PDGFR-b mRNA was more than 6 h in wild-type cells, and decreased to approximately 1 h in Shp-2 mutant cells expression of the receptor. Shp-2 appears to be speci®cally involved in the modulation of PDGFR-b expression primarily through the control of its mRNA stability. There is no alteration in protein amounts of PDGFR-a and other receptors examined in Shp-2 mutant ®broblast cells. It is also interesting to note that the heterozygous mutant cell lines have the wildtype phenotype with a normal expression of PDGFRb. This result strongly suggests that the downregulation of PDGFR-b in homozygous mutant cells can not be attributed to a dominant negative or an aberrant function of the truncated Shp-2 mutant protein, which was expressed at a much reduced level compared to the wild-type phosphatase. a b Figure 5 RasGAP and PLC-g phosphorylation. (a). Wild-type (+/ +) and Shp-2 mutant (7/7) cells were treated with PDGF-BB (50 ng/ml) for 5 min. Control and factor-stimulated cell lysates were immunoprecipitated by anti-RasGAP antibody and the resulting immunoprecipitates were subjected to immunoblot analysis using anti-phosphotyrosine (anti-PY) antibody (4G10+PY20). After striping, the ®lter was reprobed with anti-RasGAP antibody. (b). Cells were treated with PDGF-AA (50 ng/ml) for 5 or 10 min. PLCg was precipitated from control and factor-treated cell lysates by anti-PLC-g antibody, and subjected to immunoblotting with anti-PY. The ®lter was re-blotted with anti-PLC-g after striping. (c). Cells were treated with PDGF-BB (50 ng/ml) for 5 and 10 min and PLC-g phosphorylation was analysed as above Erk activation by PDGF. Serum-starved wild-type and mutant cells were treated with PDGF-BB (50 ng/ml) for 0, 5, 10, 20 and 90 min at 378C. Cell lysates were made and subjected to in vitro Erk kinase activity assay using MBP as a substrate, as described in the text A current view on growth factor-initiated intracellular signaling stands on the point that activated receptor PTKs interact with and phosphorylate SH2-containing cytoplasmic proteins, thereby transmitting signals from cell surface into cytoplasm. In this paradigm, functions of SH2-containing proteins in cell regulation rely on their recruitment to the autophosphorylated growth factor receptors. Our new results allow an intriguing proposal that a receptor substrate acts to control the expression of the receptor, a positive feedback mechanism for Shp-2 function in the control of cell growth. Therefore, the Shp-2 mutation severely suppresses mitogenic responses (Figures 6 and 7) , and the growth rate of mutant cells is also reduced, as compared to that of wild-type cells (Shi et al., 1998) .
Previous experiments demonstrated that PDGFR-b is more ecient in mediating PDGF-transforming activity than PDGFR-a (Heidaran et al., 1993) . Therefore, the speci®c function of Shp-2 in modulating PDGFR-b expression might be of important biological signi®cance in the control of cell growth. The a and b PDGFRs interact with overlapping yet distinct sets of downstream targets and, consequently, elicit dierent biological responses in cells. For example, RasGAP has higher binding anity for PDGFR-b than PDGFR-a and is eciently phosphorylated on tyrosine only in response to PDGFR-b activation (Bazenet and Kazlauskas, 1994; Heidaran et al., 1993) . Consistently, our experiments showed that RasGAP was not phosphorylated in PDGF-BB treated Shp-2 mutant cells de®cient in PDGFR-b expression.
Although Shp-2 appears to be a target of both PDGFR-aand -b, the molecular interaction of Shp-2 with the two receptors is dierent. The phosphatase binds to PDGFR-b, via tyrosine 1009 in the C-terminal tail, while it interacts with PDGFR-a via tyrosine 720 in the kinase insert region (Bazenet et al., 1996; Kazlauskas et al., 1993) . Furthermore, Shp-2 might have a regulatory eect on PDGFR-b signaling by dephosphorylating the tyrosine 751 , the PI3K binding site, and tyrosine 771 , the RasGAP-binding site (Klinghoer and Kazlauskas, 1995) . In contrast, Shp-2 has little eect on dephosphorylation of PDGFR-a (Bazenet et al., 1996) . Our results reported here add to a new function of Shp-2 in distinct modulation of the a and b PDGFRs. It should be pointed out, however, that regulation of PDGFR-b expression is obviously not the sole mechanism for Shp-2 activity in the positive control of cell growth. Although PDGFR-a is normally expressed in homozygous Shp-2 mutant cells, stimulation with either PDGF-AA or PDGF-BB failed to elicit a normal mitogenic response. An impaired induction of Erk activity and DNA synthesis was observed following PDGF treatment of mutant cells (Figures 6 and 7) , consistent with a previous report that microinjection of anti-Shp-2 antibody or a GST fusion protein containing only the SH2 domains of Shp-2 blocked PDGF-induced DNA synthesis (Roche et al., 1996) . Taken together, it is evident that Shp-2 acts to mediate mitogenic signaling through multiple mechanisms that include the control of PDGFR-b expression.
Downregulation of growth factor receptors was previously observed in cell lines transformed by v-Src. ornithine decarboxylase (ODC), or c-Haras
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, although the molecular mechanism is unknown and contradictory data exist in the literature (PaasinenSohns and Holtta, 1997; Wasilenko et al., 1990; Zhang et al., 1995) . Wasilenko et al. (1990) reported that EGFR is repressed in v-Src-transformed Rat-1 ®broblast cells, presumably due to an inhibition of EGFR biosynthesis related to a reduced level of its speci®c mRNA. It was not documented, however, whether the decrease of EGFR mRNA level is due to attenuation of transcription or poor stability of the transcript. Zhang et al. (1995) observed a decrease of PDGFR-b protein and mRNA in v-Src-transformed NRK ®broblast cells. The mechanism for the decrease of mRNA levels was also not known. A more recent report (Paasinen-Sohns and Holtta, 1997) indicated that the expression of both a and b PDGFR was suppressed in NIH3T3 cells transformed by Ras and ODC. The same group demonstrated that v-Src transformation of Rat-1 cells caused a decrease of PDGFR-b expression, while the number of PDGFR-a was not aected. This is at odds with another paper showing a clear decrease of PDGFR-a in v-Src transformed NIH3T3 cells (Lih et al., 1996) . The physiological or pathological signi®cance for repression of receptors in cells transformed by various oncogenes is not understood. It is also unclear at the molecular level how the biosynthesis of these receptors is suppressed in transformed cell lines. In the present study, we provide evidence that defective expression of PDGFR-b in Shp-2 mutant cells is primarily due to a faster decay of its mRNA. Presumably, distinct cellular signaling pathways are involved in suppression of growth factor receptors between transformed cells and Shp-2 mutant cells.
In conclusion, our results provide a fresh view on a tyrosine phosphatase as an intracellular signaling molecule. Shp-2, while a downstream target of PDGFR in signal relay, also appears to function upstream of the receptor by controling its production. At this stage, we do not rule out the possibility that the defective expression of PDGFR-b could be an indirect consequence of the Shp-2 mutation. Reconstitution of the wild-type Shp-2 expression in mutant cells will be crucial for determination of the underlying molecular mechanism.
Materials and methods
Cells and reagents
The establishment of wild-type and Shp-2 mutant embryonic ®broblast cells was previously described in detail (Shi et al., 1998) . Brie¯y, mouse embryos from the cross of Shp-2 +/7 mice under the C57BL/6 background were isolated at day 10.5 of gestation. Cell suspensions of both mutants and wild-type littermates were prepared by treatment with trypsin. Cells were seeded in 24-well plates in Dulbecco's Modi®ed Eagle's Medium (DMEM) plus 15% fetal calf serum (FCS) and were gently washed with PBS the next day to remove non-adherent cells from the culture. Fibroblast cells were immortalized with a recombinant retrovirus encoding the SV40 large T antigen (Williams et al., 1988) . Genotyping of cell lines was performed by immunoblot analysis using anti-Shp-2 (C-18) antibody (Santa Cruz Biotechnology Inc). Anti-PDGFR-b antibody was kindly provided by Dr Andrius Kazlauskas (Harvard Medical School) . Antibodies to PDGFR-a and insulin-like growth factor-I receptor (IGF-IR) were purchased from Upstate Biotechnology Inc and antibodies against Shp-2, PLC-g, RasGAP and epidermal growth factor receptor (EGFR) were from Santa Cruz Biotechnology, Inc.
Immunoprecipitation and immunoblotting
For growth factor stimulation, semi-con¯uent cells were starved for 36 h in DMEM with 0.1% FCS, stimulated for 5 min with PDGF-BB (50 ng/ml), washed twice in cold phosphate-buered saline (PBS), and lysed in RIPA buer (PBS, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, freshly supplemented with 1 mM Na 3 VO 4 , 1 mM ZnCl 2 , 1 mM PMSF, 20 mg/ml aprotinin, 20 mg/ml leupeptin). Equal amounts of cell lysates were immunoprecipitated by speci®c antibodies in the presence of protein G/Asepharose beads. The resulting immunoprecipitates or cell lysates were resolved on SDS-polyacrylamide gels, transferred to nitrocellulose ®lters and blotted with speci®c antibodies. Immunoblots were developed using an enhanced chemiluminescence (ECL) kit (Amersham).
Northern blotting and nuclear run-on assay
Total RNA was extracted from cells with the guanidinium method (Ausubel et al., 1994) . After electrophoresis on 1% agarose gel containing formaldehyde, the RNA was transferred to a nylon ®lter and Northern blot analysis was performed according to a standard protocol (Ausubel et al., 1994) , using cDNA fragments of PDGFR-a or PDGFR-b as probes (Soriano, 1994) . Puri®ed cDNAs were labeled with a 32 P-dCTP using a random primer labeling kit (Boehringer Mannheim).
Nuclear run-on assays were conducted with nuclei collected from 3610 7 cells of wild-type and mutant origins as previously described (Greenberg and Zi, 1984) . Identical amounts of a 32 P-UTP-labeled run-on transcripts were hybridized to Zeta-Probe membranes slot-blotted with denatured plasmids containing mouse PDGFR-a, PDGFRb, GAPDH cDNA inserts as well as the pBluescript vector as a control. After washing, ®lters were exposed to X-ray ®lms for 72 h at 7708C.
RT ± PCR analysis
Quantitative RT ± PCR analysis was performed as described previously (Qu et al., 1997) . Total RNA was extracted by using the RNeasy Total RNA kit from QIAGEN. RNA samples were digested with DNase to eliminate any remaining genomic DNA. A random hexamer-primed cDNA strand was synthesized with reverse transcriptase (RT) from mouse mammary leukemia virus. The RT products were used as templates for PCR ampli®cation by using gene-speci®c primers. The relative expression of the house-keeping gene HPRT was used as an internal control. Using a series of dilution of the cDNA synthesized from known amounts of total RNA, PCR was performed with a pair of primers (CACAGGACTAGAA-CACCTGC and GCTGGTGAAAAGGACCTCT) speci®c for HPRT (Weiss et al., 1994) , which gave rise a 249 bp PCR product. PCR ampli®cation eciency was determined empirically by checking the amounts of PCR products on agarose gel after various cycles to maintain ampli®cation in a linear range, which permited comparison of the relative levels of speci®c mRNAs among dierent samples. For quanti®cation of PDGFR-b mRNA levels, a pair of primers (GGCTCGAGACATCATGAGGGA and TCAA-GGTGGAACTGGCAAGGC) speci®c for mouse PDGFRb (Yarden et al., 1986) was used, which yielded a 600 bp PCR product.
Measurement of DNA synthesis
Wild-type (+/+) and Shp-2 mutant (7/7) cells were seeded at 5610 4 cells/well in DMEM with 10% FCS in 96-well plates. After 24 h, the medium was changed to serumfree DMEM for starvation for 48 h. Cells were replenished with DMEM containing 0.1 mg/ml BSA plus PDGF-AA or PDGF-BB (10, 50, 100 ng/ml), and incubated for another 24 h. At the last 6 h, each well was added 1 mCi [ 3 H]thymidine. Samples were collected on ®lters by a cell harvest machine and [ 3 H]thymidine incorporation was measured by a liquid scintillation counter.
In vitro Erk kinase assay
Erk kinase was precipitated by speci®c antibody raised against Erk1, in the presence of protein-A sepharose 4B beads. The immune complexes on beads were washed twice with HNTG buer (McGlade et al., 1992) , and once with the kinase buer (20 mM HEPES, pH 7.5, 10 mM MgCl 2 , 2 mM 2-mercaptoethanol, 1 mM Na 3 VO 4 ), Kinase assay was performed by mixing the beads with 1 mg/ml myelin basic protein (MBP), 80 mM ATP, 1.5 mCi[g-32 P]ATP in 20 ml kinase buer and incubated for 10 min at 308C. After spinning in a microcentrifuge, supernatants were spotted on P81 Whatman papers and the papers were washed ®ve times in 180 mM phosphoric acid, once in 100% ethanol, air-dried and then counted.
